drugset / Trial / NCT00514995
Sodium Oxybate in the Treatment of Binge Eating Disorder
Phase 2/3
Completed
15 enrolled
Lindner Center of HOPE
Jazz Pharmaceuticals · collabUniversity of Cincinnati · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to study the effectiveness, tolerability and safety of sodium oxybate in outpatients with binge eating disorder.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Oxybate | Unknown | 4.5 g | — |
| Subject | Sodium Oxybate | Unknown | 9 g | — |